Spotlight On... Google discloses 30 grant winners in disabilities innovation challenge; Cambridge researchers image cancer drug effectiveness; NIH backs Phase II tissue-integrated oxygen sensor study; and more...

Google will award a series of grants of roughly $500,000 to $1.5 million apiece to the 30 nonprofit winners of its Impact Challenge for innovative technology to address the needs of the disabled. They include The Center for Discovery, which received $1.1 million to develop an add-on device to make any wheelchair power-driven; Ezer Mizion and Click2Speak, which got $400,000 to create an on-screen keyboard that can be used without hands; and the ProPortion Foundation, which got $1 million to develop a fully automated device that creates high-quality sockets for prosthetics. More

@FierceMedDev: ICYMI yesterday: Medtronic shut down study of Infuse bone graft and hid the evidence: Report. More | Follow @FierceMedDev

@EmilyWFierce: Incoming Bayer CEO looks to deals to beef up $1.7B animal health unit. FiercePharma article | Follow @EmilyWFierce

> Cambridge, U.K.-based researchers have developed an imaging technique designed to let physicians see if anti-cancer drugs are proving effective within a day or two of starting treatment. More

> Small-cap AtriCure ($ATRC) has received FDA clearance for its CryoForm Cryoablation Probe for use in cardiac arrhythmia surgical ablation procedures. It was launched in Europe in October 2015. More

> Profusa has nabbed a $1.75 million Small Business Innovation Research (SBIR) grant under the National Heart, Lung, and Blood Institute (NHLBI) to support Phase II research for its Lumee tissue-integrated biosensors that continuously monitor oxygen in peripheral artery disease patients. More

Biotech News

@FierceBiotech: ICYMI: Roche/AbbVie team scores 'breakthrough' FDA OK of leukemia drug venetoclax. News | Follow @FierceBiotech

@JohnCFierce: ICYMI: $125M Regeneron deal in hand, CRISPR/Cas9 star Intellia files for IPO. Report | Follow @JohnCFierce

> Forbion raises $200M for EU and North American biotechs, funds to focus on unmet needs. News

> 4D Pharma acquires Spanish CRO Instituto Biomar, buys into its microbial fermentation service. Story

> London University spin-off hails new tooth repair technology 'while you sleep.' More

Pharma News

@FiercePharma: Obama aides focus on overall pharma benefits in TPP, not biologics data period. More from FiercePharmaAsia | Follow @FiercePharma

@CarlyHFierce: ICYMI from FiercePharmaMarketing: Ironwood exec's brainstorm gives Allergan a marketing edge with Linzess. More | Follow @CarlyHFierce

> Incoming Bayer CEO looks to deals to beef up $1.7B animal health unit. Article

> Merck CEO Frazier scores $24.2M for 2015, earning a spot among pharma's highest-paid. Story

> Does Biogen selling its hemophilia franchise make sense? Leerink's top analyst says yes. More

Pharma Manufacturing News

> $60M Eli Lilly warehouse heist not the fault of security firm, jury says. Article

> Spanish regulators recall Inmunotek vaccines, suspend manufacturing at Madrid facility. Story

> Recipharm closes deal for Indian sterile injectables maker. More

> FDA bans products from 3 more Chinese drugmakers. Item

> J&J gets FDA approval for continuous manufacturing of Prezista. Report

Drug Delivery News

> GE Ventures, Mayo Clinic launch new personalized cell and gene therapy biz. News

> Phase III testing data looks promising for Highland's ADHD drug Benjorna. More

> Two-faced pill releases drugs to GI lining, and its smooth side keeps it stable. Report

> Oasmia reports affirming results in recent trial of XR-17 nanotechnology delivery platform. Story

> IBM to open its first Watson Health European Center of Excellence in Italy. Article

Pharma Asia News

> Genetic tests identify 6 types of liver cancer among Japanese patients. More

> Obama aides focus on overall pharma benefits in TPP, not biologics data period. Story

> Singapore's NMT pumps equity into CAO TCM-derived oncology play. Item

> After raising a $101M IPO, Chi-Med begins first blood cancer trial in Australia. Report

> Korea's CJ HealthCare signs next-gen Nexium pact with China's Shandong Luoxin. Article